2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|
营业收入(元) | ||||
B型硬脑(脊)膜补片(元) | 59,368,133.28 | 27,289,754.10 | 49,099,926.27 | 23,852,947.33 |
本维莫德乳膏(元) | 49,438,451.80 | 32,441,303.36 | 34,354,885.49 | 28,531,449.32 |
代理产品(元) | 88,618,801.79 | 36,104,374.33 | 79,823,839.73 | 41,554,136.41 |
护肤品(元) | 688,133.45 | 297,108.12 | 953,095.19 | 646,636.94 |
脑膜建-生物型硬脑(脊)膜补片(元) | 87,661,292.74 | 43,408,051.25 | 88,124,486.32 | 47,683,525.67 |
人工晶体(元) | - | 10,989,735.91 | 26,497,280.04 | 14,647,323.15 |
乳房补片(元) | 1,927,799.85 | 1,109,703.75 | 1,791,656.73 | 937,905.30 |
细胞技术服务(元) | 50,266,667.94 | 26,535,451.40 | 40,447,418.36 | 17,254,792.52 |
胸普外科修补膜(元) | 40,490,163.06 | 21,176,774.14 | 31,348,209.78 | 15,678,102.01 |
无菌生物护创膜(元) | 11,031,427.75 | 5,446,785.93 | 9,529,642.45 | 3,001,224.87 |
租赁服务(元) | 14,687,825.59 | - | 15,314,573.84 | - |
其他主营业务(元) | - | - | - | 3,001,224.87 |
其他业务(元) | - | - | - | 9,089,032.50 |
营业成本(元) | ||||
B型硬脑(脊)膜补片(元) | 9,119,524.79 | 3,602,331.54 | 5,829,727.71 | 2,966,310.29 |
本维莫德乳膏(元) | 9,386,900.92 | 6,062,169.77 | 8,726,724.32 | 7,272,558.81 |
代理产品(元) | 30,316,001.02 | 11,596,531.58 | 29,537,823.79 | 12,738,340.24 |
护肤品(元) | - | 375,537.72 | - | 474,359.56 |
脑膜建-生物型硬脑(脊)膜补片(元) | 7,735,297.11 | 2,944,619.61 | 3,690,654.15 | 3,425,639.93 |
人工晶体(元) | - | 10,178,983.33 | 16,807,804.81 | 8,108,789.17 |
乳房补片(元) | - | 468,656.41 | 876,501.14 | 517,519.38 |
细胞技术服务(元) | 8,952,530.69 | 2,642,316.95 | 7,113,897.44 | 3,740,118.17 |
胸普外科修补膜(元) | 4,440,592.98 | 2,273,289.26 | 2,496,995.20 | 1,280,407.62 |
无菌生物护创膜(元) | - | 482,295.32 | 892,684.69 | 246,570.21 |
租赁服务(元) | - | - | - | - |
其他主营业务(元) | - | - | - | 246,570.21 |
其他业务(元) | - | - | - | 7,886,122.21 |
毛利(元) | ||||
B型硬脑(脊)膜补片(元) | 50,248,608.49 | 23,687,422.56 | 43,270,198.56 | 20,886,637.04 |
本维莫德乳膏(元) | 40,051,550.88 | 26,379,133.59 | 25,628,161.17 | 21,258,890.51 |
代理产品(元) | 58,302,800.77 | 24,507,842.75 | 50,286,015.94 | 28,815,796.17 |
护肤品(元) | - | -78,429.60 | - | 172,277.38 |
脑膜建-生物型硬脑(脊)膜补片(元) | 79,925,995.63 | 40,463,431.64 | 84,433,832.17 | 44,257,885.74 |
人工晶体(元) | - | 810,752.58 | 9,689,475.23 | 6,538,533.98 |
乳房补片(元) | - | 641,047.34 | 915,155.59 | 420,385.92 |
细胞技术服务(元) | 41,314,137.25 | 23,893,134.45 | 33,333,520.92 | 13,514,674.35 |
胸普外科修补膜(元) | 36,049,570.08 | 18,903,484.88 | 28,851,214.58 | 14,397,694.39 |
无菌生物护创膜(元) | - | 4,964,490.61 | 8,636,957.76 | 2,754,654.66 |
租赁服务(元) | - | - | - | - |
其他主营业务(元) | - | - | - | 2,754,654.66 |
其他业务(元) | - | - | - | 1,202,910.29 |
毛利率(%) | ||||
B型硬脑(脊)膜补片(%) | 84.64 | 86.80 | 88.13 | 87.56 |
本维莫德乳膏(%) | 81.01 | 81.31 | 74.60 | 74.51 |
代理产品(%) | 65.79 | 67.88 | 63.00 | 69.35 |
护肤品(%) | - | -26.40 | - | 26.64 |
脑膜建-生物型硬脑(脊)膜补片(%) | 91.18 | 93.22 | 95.81 | 92.82 |
人工晶体(%) | - | 7.38 | 36.57 | 44.64 |
乳房补片(%) | - | 57.77 | 51.08 | 44.82 |
细胞技术服务(%) | 82.19 | 90.04 | 82.41 | 78.32 |
胸普外科修补膜(%) | 89.03 | 89.27 | 92.03 | 91.83 |
无菌生物护创膜(%) | - | 91.15 | 90.63 | 91.78 |
租赁服务(%) | - | - | - | - |
其他主营业务(%) | - | - | - | 91.78 |
其他业务(%) | - | - | - | 13.23 |
收入构成(%) | ||||
B型硬脑(脊)膜补片(%) | 14.69 | 13.33 | 13.01 | 11.59 |
本维莫德乳膏(%) | 12.23 | 15.84 | 9.11 | 13.86 |
代理产品(%) | 21.93 | 17.63 | 21.16 | 20.18 |
护肤品(%) | 0.17 | 0.15 | 0.25 | 0.31 |
脑膜建-生物型硬脑(脊)膜补片(%) | 21.69 | 21.20 | 23.36 | 23.16 |
人工晶体(%) | - | 5.37 | 7.02 | 7.11 |
乳房补片(%) | 0.48 | 0.54 | 0.47 | 0.46 |
细胞技术服务(%) | 12.44 | 12.96 | 10.72 | 8.38 |
胸普外科修补膜(%) | 10.02 | 10.34 | 8.31 | 7.62 |
无菌生物护创膜(%) | 2.73 | 2.66 | 2.53 | 1.46 |
租赁服务(%) | 3.63 | - | 4.06 | - |
其他主营业务(%) | - | - | - | 1.46 |
其他业务(%) | - | - | - | 4.41 |
毛利构成(%) | ||||
B型硬脑(脊)膜补片(%) | 16.43 | 14.43 | 15.18 | 13.31 |
本维莫德乳膏(%) | 13.09 | 16.07 | 8.99 | 13.54 |
代理产品(%) | 19.06 | 14.93 | 17.64 | 18.36 |
护肤品(%) | 0.00 | -0.05 | 0.00 | 0.11 |
脑膜建-生物型硬脑(脊)膜补片(%) | 26.13 | 24.65 | 29.62 | 28.19 |
人工晶体(%) | - | 0.49 | 3.40 | 4.17 |
乳房补片(%) | 0.00 | 0.39 | 0.32 | 0.27 |
细胞技术服务(%) | 13.51 | 14.55 | 11.69 | 8.61 |
胸普外科修补膜(%) | 11.79 | 11.51 | 10.12 | 9.17 |
无菌生物护创膜(%) | 0.00 | 3.02 | 3.03 | 1.75 |
租赁服务(%) | 0.00 | - | 0.00 | - |
其他主营业务(%) | - | - | - | 1.75 |
其他业务(%) | - | - | - | 0.77 |